Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
FTD) combined with the metabolic inhibitor of thymidine phosphorylase
was developed as a highly potent and selective enhancer of the chaperone-mediated autophagy (CMA) through antagonizing RARα
Molecular Weight: 1648
Formula: C19H42BrN
0000000000002660
6-Hydroxyazepan-2-one alacic acid FTD) combined with the metabolicIsavuconazole (BAL4815; trade name Cresemba) is a triazole antifungal drug. Its prodrug, isavuconazonium sulfate (BAL8557), was granted approval by the U. S. Food and Drug Administration (FDA) on March 6, 2015. Isavuconazole has been approved for treatment of invasive aspergillosis and invasive mucormycosis in adults ages 18 years and older. Both infections are caused by mold and fungi common to the environment, and occur in individuals who are
US$ 173.50
US$ 100.50
US$ 44.00
US$ 53.60